AHA Science

Your research. Our support. A healthier future.

From bold ideas to lifesaving breakthroughs, your research starts here. Grant applications are open to help you shape the future of health.

Advancing science. Advancing you.

Fuel your discoveries with funding, mentorship and the powerful research network of the American Heart Association. Don’t miss a chance to advance science and save lives. Applications are open.

ISC26 is 50 days away

It’s not too late to save your spot for #ISC26! Be part of this global gathering of experts changing the future of stroke and brain health science.

See you in New Orleans in 50 days!

Turn Your Passion Into Progress.

Your research has the power to save lives. An American Heart Research Awards gives you the support to make it happen. Applications are open!

Scientific Sessions 2025 Late Breaking Science 1 of 3

Scientific Sessions 2025 Late Breaking Science 2 of 3

Scientific Sessions 2025 Late Breaking Science 3 of 3

ICYMI here are results from all 17 LBS presentations at #AHA25. Missed them?

Check them out on Scientific Sessions OnDemand coming in early December.

Research Awards: fueling breakthroughs. Empowering you.

Advance your research with the support you deserve. We anticipate that about 1,000 grants will be awarded this year to help you advance science and save lives. Applications are open now.

DAPT-MVD results presented at #AHA25

DAPT-MVD results presented at #AHA25

CELEBRATE results presented at #AHA25

CELEBRATE results presented at #AHA25

The TOP trial is a parallel, single-blind, randomized, clinical superiority trial, N=1424 that sought to determine whether liberal versus restrictive transfusion strategy after major general and vascular surgery reduces adverse outcomes in high cardiac risk patients.

Sunil Rao, MD on the results.

ANGPTL3, presented at #AHA25 showed gene editing demonstrates few adverse events.

More from Dr. Harrington👇👇

Calling all coffee drinkers! Dr. Khan has good news from the DECAF trial presented at #AHA25. ☕☕☕

DECAF results presented at #AHA25

DECAF results presented at #AHA25

What is the potential clinical impact of the OPTIMA trial?

Here is one prediction. #AHA25

In patients with AF who are stable beyond one year of drug-eluding stent implantation NOAC monotherapy provides a simple and safe long-term therapy versus combination therapy.

📢 Adding evolocumab to lipid-lowering therapy significantly reduced the risk of a first major CV event in patients without prior heart attack or stroke.

#AHA25 ⬇️

The study demonstrates that DR10624 can lead to significant reductions in triglycerides with favorable safety and tolerability results.

Shayan Mohammadmoradi's, MS, PhD take on the data presented at #AHA25

PREVENT equation 🤝 cardiovascular kidney metabolic health

Learn more about CKM and PREVENT at #AHA25

VESALIUS-CV results presented at #AHA25

VESALIUS-CV results presented at #AHA25

ANGPTL3 results presented at #AHA25

ANGPTL3 results presented at #AHA25

DR10624 results presented at #AHA25

DR10624 results presented at #AHA25

Register now to save at ISC26

Get the best price for #ISC26 now! Join us in New Orleans and help change the future of stroke science and brain health.

ISC26 CFA extension

📢 #ISC26 CFA submission deadline extended

Your research deserves the spotlight—submit your International Stroke Conference abstract by Oct. 30 at 11:59 p.m. ET.

Don’t miss your chance to share your science on the world stage.

ISC26 is 100 days away

100 days go by faster than you think! Don’t wait to save your spot for #ISC26.

Your Research. Our Support. A Healthier Future.

From bold ideas to lifesaving breakthroughs, your research starts here. Grant applications are open to help you shape the future of health.

AHA25 Health Innovation Pavilion Programming

The Health Innovation Pavilion is back at #AHA25 with three days of insightful panel discussions, live tech demos and the Health Tech Competition.

Stop by the Science & Technology Hall to see what’s next – and what’s possible in cardiovascular and digital health.

See you in New Orleans!

CKM programming at AHA25

3 out of 4 U.S. adults have reversible CKM syndrome, but care is often fragmented and treatment delayed. Ready to learn more about cardiovascular-kidney-metabolic health for your patients? Add these sessions to your #AHA25 planner. ⬇️

TCT at AHA

Get expert insights in interventional cardiology through TCT at AHA. We’re excited to once again welcome the Cardiovascular Research Foundation to Scientific Sessions. Join us at #AHA25 and be part of the future of cardiovascular innovation and research.

ISC26 LBS Submissions Open - Submit by Oct 29

Help change the future of stroke science and brain health. Submit your late-breaking abstract for #ISC26 before Oct. 29.

Advanced pricing for AHA25 Ends October 6

What’s new at Scientific Sessions 2025?

👉 Four full days of programming
👉 More immersive experiences in AI, simulation, and hands-on innovation
👉 More basic science sessions featuring the latest in scientific discovery
👉 Scientific Sessions OnDemand is now a built-in member benefit

TCT@AHA25

📣 TCT at AHA, your chance to learn the latest in interventional cardiology.

Cardiovascular Research Foundation is joining #AHA25 to deliver late-breaking science and expert insights on structural heart interventions, complex PCI and next-generation techniques.

We’ll see you in New Orleans.